Nagesh Mahanthappa
Chairman en Exo Therapeutics, Inc. .
Fortuna: 8 M $ al 31/03/2024
Perfil
Nagesh K.
Mahanthappa is the founder of TwistDX, Inc. (founded in 2010) and TwistDX Ltd.
(founded in 2002).
He currently holds the position of Executive Chairman at Exo Therapeutics, Inc. since 2023, Independent Director at Casma Therapeutics, Inc. since 2020, Non-Executive Director at Camena Bioscience Ltd.
since 2016, and Independent Director at Abata Therapeutics, Inc. since 2021.
He has previously served as President, Chief Executive Officer & Director at Scholar Rock, Inc. from 2012 to 2020 and President, Chief Executive Officer & Director at Scholar Rock Holding Corp.
from 2021 to 2022.
Dr. Mahanthappa has also held positions at Medtronic, Inc., Merck & Co., Inc., Vertex Pharmaceuticals, Inc., Novartis AG, Ontogeny, Inc., Alnylam Pharmaceuticals, Inc., and Avila Therapeutics, Inc. He has a doctorate degree from the California Institute of Technology, an undergraduate degree from The University of Colorado, and an MBA from F.W.
Olin Graduate School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/03/2023 | 464 086 ( 0.60% ) | 8 M $ | 31/03/2024 |
Cargos activos de Nagesh Mahanthappa
| Empresas | Cargo | Inicio |
|---|---|---|
Camena Bioscience Ltd.
 Camena Bioscience Ltd. BiotechnologyHealth Technology Camena Bioscience Ltd. is a British biotechnology company that produces long and complex synthetic genes. The company is based in Cambridge, UK. Camena Bioscience was founded in 2016 by Steve Harvey. Steve Harvey has been the CEO since 2016. | Director/Board Member | 01/11/2016 |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA. | Director/Board Member | 17/11/2020 |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Chairman | 04/01/2023 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Director/Board Member | - |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Director/Board Member | 29/07/2021 |
Antiguos cargos conocidos de Nagesh Mahanthappa.
| Empresas | Cargo | Fin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Chief Executive Officer | 20/10/2022 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Executive Officer | 01/08/2020 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Chief Executive Officer | 01/08/2020 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Chief Operating Officer | 01/05/2012 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Nagesh Mahanthappa.
| California Institute of Technology | Doctorate Degree |
| The University of Colorado | Undergraduate Degree |
| F.W. Olin Graduate School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| NOVARTIS AG | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Empresas privadas | 11 |
|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
TwistDX, Inc.
 TwistDX, Inc. Miscellaneous Commercial ServicesCommercial Services TwistDX, Inc. provides scientific research and development services. The private company is based in Cambridge, MA. The company was founded by Nagesh K. Mahanthappa. | Commercial Services |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
TwistDx Ltd.
 TwistDx Ltd. BiotechnologyHealth Technology Part of Abbott Laboratories, TwistDx Ltd. is a British company that specializes in recombinase polymerase amplification technology. The private company is based in Maidenhead, UK. The company offers TwistAmp research kits for researchers to develop tests, assays, and kits relevant to their work in fields such as water testing, biodefense, food species verification, and clinical or veterinary diagnostics. The company can work with partners on specific assay development collaborations for research and commercial applications. The company offers devices and accessories for research and development use only. The company was founded in 2002 by Niall Armes, Derek Stemple, Nagesh K. Mahanthappa. | Health Technology |
Casma Therapeutics, Inc.
Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA. | Commercial Services |
Camena Bioscience Ltd.
Camena Bioscience Ltd. BiotechnologyHealth Technology Camena Bioscience Ltd. is a British biotechnology company that produces long and complex synthetic genes. The company is based in Cambridge, UK. Camena Bioscience was founded in 2016 by Steve Harvey. Steve Harvey has been the CEO since 2016. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Health Technology |
- Bolsa de valores
- Insiders
- Nagesh Mahanthappa
